|
[Related PubMed/MEDLINE]
Total Number of Papers: 28
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
FDXR Gene Expression after in Vivo Radiation Exposure of Pediatric Patients Undergoing Interventional Cardiology Procedures. |
IC, PKA, RQ |
| 2 |
2022 |
Transcriptional Dynamics of DNA Damage Responsive Genes in Circulating Leukocytes during Radiotherapy. |
DDR, DSBs, IR |
| 3 |
2021 |
Biological dosimetry and modern (-omic) methods. |
--- |
| 4 |
2021 |
Ferredoxin reductase regulates proliferation, differentiation, cell cycle and lipogenesis but not apoptosis in SZ95 sebocytes. |
IGF-1, ROS |
| 5 |
2021 |
Report of a case with ferredoxin reductase (FDXR) gene variants in a Chinese boy exhibiting hearing loss, visual impairment, and motor retardation. |
Fe-S |
| 6 |
2021 |
Steroidogenic electron-transfer factors and their diseases. |
Fdx |
| 7 |
2020 |
Elucidation of Mechanisms of Topotecan-Induced Cell Death in Human Breast MCF-7 Cancer Cells by Gene Expression Analysis. |
GPx, GSR, Msr |
| 8 |
2020 |
Expanding the clinical and genetic spectrum of FDXR deficiency by functional validation of variants of uncertain significance. |
--- |
| 9 |
2020 |
FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression. |
FDX1, IRP2, MEFs, WT |
| 10 |
2020 |
In Vivo Validation of Alternative FDXR Transcripts in Human Blood in Response to Ionizing Radiation. |
IR, qPCR |
| 11 |
2020 |
Integrated analysis of the molecular pathogenesis of FDXR-associated disease. |
CNS, ETC, ROS |
| 12 |
2018 |
Biallelic mutations in FDXR cause neurodegeneration associated with inflammation. |
--- |
| 13 |
2018 |
In vivo Exposure Effects of 99mTc-methoxyisobutylisonitrile on the FDXR and XPA Genes Expression in Human Peripheral Blood Lymphocytes. |
LNT, PBMNs, qRT-PCR, XPA |
| 14 |
2017 |
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2. |
IRP2 |
| 15 |
2017 |
Suppression of progesterone synthesis in human trophoblast cells by fine particulate matter primarily derived from industry. |
APO, cAMP, hCG, PKA |
| 16 |
2016 |
Examining Radiation-Induced In Vivo and In Vitro Gene Expression Changes of the Peripheral Blood in Different Laboratories for Biodosimetry Purposes: First RENEB Gene Expression Study. |
EU-RENB, LINAC |
| 17 |
2015 |
EglN2 associates with the NRF1-PGC1alpha complex and controls mitochondrial function in breast cancer. |
NRF1 |
| 18 |
2015 |
Ferredoxin Reductase Is Useful for Predicting the Effect of Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma. |
CRT, ESCC, ROS |
| 19 |
2010 |
Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. |
CCNG1, CDKN1A, GADD45A, MDM2, MQRT- PCR, SESN1 |
| 20 |
2010 |
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer. |
5-FU, DFS, DUT, TP53 |
| 21 |
2009 |
Fragile gene product, Fhit, in oxidative and replicative stress responses. |
ROS |
| 22 |
2008 |
Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions. |
FHIT |
| 23 |
2008 |
Fhit tumor suppressor: guardian of the preneoplastic genome. |
--- |
| 24 |
2006 |
Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. |
UVR |
| 25 |
2006 |
Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin. |
5-FU, LV |
| 26 |
2004 |
Genetic variation in radiation-induced expression phenotypes. |
CDKN1A |
| 27 |
2003 |
Ferredoxin reductase: pharmacogenomic assessment in colorectal cancer. |
SNPs |
| 28 |
2002 |
Isolation, physical mapping and polymorphism of the porcine ferredoxin reductase (FDXR ) gene. |
--- |
|
A Search Service for Abbreviation / Long Form
